Purchase Order 75N92020P00181
Award Date
7/10/20
Potential Completion Date
3/31/22
Potential Value
$38K
Federal Agency
National Heart Lung and Blood Institute
Awardee
Reprocell U.s.a., Inc.
Ultimate Awardee
Not listed
NAICS Category
541380 - Testing Laboratories and Services
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Morrisville, NC, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order contract awarded by the National Human Genome Research Institute (NHGRI), a civilian agency within the National Institutes of Health (NIH), to Reprocell U.S.A., Inc. for $17,016.80. The contract was awarded on January 5, 2023 with a completion date of July 5, 2023. The contract supports genetic and epigenetic analysis at the transcriptome level, which is a critical component of the Comprehensive Disease Study (CDS) program's integrative research...
The federal contract award 75N95D24P00067 was made by the National Institute on Aging (NIA), a civilian agency within the U.S. government, to Reprocell U.S.A., Inc., a for-profit organization, for laboratory testing services related to RNA and DNA extraction from mouse and human models. The $20,902.50 firm fixed price contract has a period of performance through July 30, 2024. The contract was awarded under full and open competition with no set-aside designation. Reprocell U.S.A., Inc. has...
This federal contract was awarded by a U.S. government agency to Reprocell U.S.A., Inc., a for-profit organization that specializes in providing biological materials and related services to support biomedical research. The contract is for DNA sample analysis, with a firm fixed price of $73,647.00 and a completion date of April 30, 2008. The work is being performed in Laurel, Maryland and was awarded on May 1, 2007 without any set-aside designation. Reprocell U.S.A., Inc. has primarily worked...
The National Institutes of Health (NIH) National Human Genome Research Institute (NHGRI) awarded a $119,200.00 firm fixed-price purchase order to Norgen Biotek Corp, a Canadian for-profit manufacturer, to provide exosome extraction services in support of future RNA sequencing work for NHGRI. This award is not associated with a set-aside program. Through previous federal contracts valued between $16,464 and $668,710, Norgen Biotek has provided similar exosome and extracellular RNA extraction,...
This is a purchase order contract awarded by the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH), to Norgen Biotek Corp, a Canadian for-profit manufacturer of biotechnology products and services. The contract, valued at $149,840, is for the provision of exosome and extracellular RNA extraction, isolation, purification, and sequencing services to support clinical research studies at NIH. Norgen Biotek has previously been awarded over $1 million in...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) Clinical Center awarded a $198,597.49 firm-fixed-price purchase order contract to Life Technologies Corporation, a for-profit manufacturer, to supply specialized reagents and disposables to support the NIH's cellular therapy research and treatment programs. The contract is for a base year with three option years, providing reagents and supplies to enable the processing of approximately 100 cellular therapy...
The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a firm fixed price purchase order valued at approximately $668,710 to Norgen Biotek Corp. of Ottawa, Canada. Under the terms of the contract, Norgen Biotek will extract and isolate intact RNA exosomes from plasma samples to support an unspecified clinical study being conducted by the National Heart, Lung and Blood Institute. The original solicitation sought proposals for...
The Department of Health and Human Services' National Institutes of Health National Human Genome Research Institute (NHGRI) awarded a firm-fixed-price purchase order to Norgen Biotek Corp, a Canadian for-profit manufacturer, to provide exosome extraction services for future RNA sequencing. The potential value of the contract is $165,000.00, and the period of performance is from the award date of June 25, 2019, to the completion date of June 24, 2021. Norgen Biotek Corp has previously provided...
The National Heart Lung and Blood Institute (NHLBI), a civilian agency within the National Institutes of Health (NIH), awarded a $34,966 firm fixed-price purchase order to Mission Bio, Inc., a for-profit manufacturer of biological supplies and sequencing services. The contract is for the delivery of Tapestri Single-Cell DNA + Protein Reagent Kits to support NHLBI's biomedical research and genomics efforts. The contract has a performance period through December 19, 2025 and does not utilize any...
This is a firm-fixed-price purchase order contract awarded by the National Institute on Deafness and Other Communication Disorders (NIDCD), a civilian agency within the National Institutes of Health (NIH), to Advanced Cell Diagnostics, Inc. (ACD), a for-profit manufacturer of goods specializing in advanced RNA detection technologies. The $11,208.00 contract is for the provision of 8 kits of reagents for RNAscope experiments, which are critical for biomedical research efforts across various...